Tough Times Ahead For Towa As Japanese Generics Giant Slashes 2023 Predictions

Net Profits In Q2 Down Over 70%

Man holding graph chart arrow that's pointing down
Towa's expectations for the year ahead have taken a downward turn • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business